
Building a brighter future with patient support programmes
Scientific and digital development has created a ‘new build’ surge across the pharma landscape. Bold structures are appearing at a whirlwind pace, towering above the pre- pandemic skyline with their promise and ambition. The high-rise promise of cell and gene therapy is the new architecture









